Drug intelligence / Profile preview

high THC cannabis

Development stage
Unknown
Lead developer
Lykos Therapeutics
Modality
Small Molecules
Administration
Inhalation
01

Overview

High THC cannabis is an investigational whole-plant botanical product being developed by the Multidisciplinary Association for Psychedelic Studies (MAPS) for the treatment of chronic, treatment-resistant posttraumatic stress disorder (PTSD) in military veterans. The product consists of smoked cannabis containing approximately 12% tetrahydrocannabinol (THC) and less than 0.05% cannabidiol (CBD). Sourced from the National Institute on Drug Abuse (NIDA), it acts as an agonist at cannabinoid receptors (CB1 and CB2) within the endocannabinoid system. This intervention was evaluated in the Phase 2 MJP1 trial, a randomized, triple-blind, placebo-controlled crossover study designed to assess the safety and efficacy of different cannabis potencies in reducing PTSD symptom severity as measured by the CAPS-5 scale.

Other names
High THC/Low CBD cannabisSmoked cannabisBotanical marijuanaHigh THC cannabis-Multidisciplinary Association for Psychedelic Studies-posttraumatic stress disorder
02

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on high THC cannabis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on high THC cannabis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call